Cargando…
Bleeding recurrence in patients with gastrointestinal vascular malformation after thalidomide
Thalidomide may be used for the treatment of gastrointestinal vascular malformation (GIVM), but the long-term response and adverse effects are unknown. Aim to study the recurrence rate of GIVM bleeding after thalidomide treatment, the response to treatment, and the adverse effects. This was a retros...
Autores principales: | Chen, Haiying, Fu, Sengwang, Feng, Nan, Chen, Huimin, Gao, Yunjie, Zhao, Yunjia, Xue, Hanbing, Zhang, Yao, Li, Xiaobo, Dai, Jun, Fang, Jingyuan, Ge, Zhizheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370822/ https://www.ncbi.nlm.nih.gov/pubmed/27537596 http://dx.doi.org/10.1097/MD.0000000000004606 |
Ejemplares similares
-
HIF-1α and HIF-2α induced angiogenesis in gastrointestinal vascular malformation and reversed by thalidomide
por: Feng, Nan, et al.
Publicado: (2016) -
Thalidomide for refractory gastrointestinal bleeding from vascular malformations in patients with significant comorbidities
por: Bayudan, Alexis Mae, et al.
Publicado: (2020) -
Acute gastrointestinal bleeding: A comparison between variceal and nonvariceal gastrointestinal bleeding
por: Raţiu, Iulia, et al.
Publicado: (2022) -
Thalidomide induces mucosal healing in postoperative Crohn disease endoscopic recurrence: Case report and literature review
por: Hu, Huiqin, et al.
Publicado: (2016) -
Thalidomide for inflammatory bowel disease: Systematic review
por: Bramuzzo, Matteo, et al.
Publicado: (2016)